A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 85
SponsorXiling Qi

About this trial

This study investigates the effects of a sequential "lying-sitting-standing" Baduanjin intervention on patients with acute coronary syndrome complicated by heart failure. By evaluating cardiopulmonary function and quality of life through indicators such as echocardiography, NT-proBNP, 6MWT, NYHA classification, and SF-36, we aim to compare its efficacy with conventional treatment. The objective is to provide new insights for early cardiac rehabilitation strategies in patients with acute coronary syndrome complicated by heart failure

Eligibility criteria

Qualifiers

Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction)

Complicated by heart failure during hospitalization

Age ≤ 85 years

Muscle strength ≥ grade 3

Disqualifiers

Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy;

Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability;

Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease;

Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure;

Trial design

Treatments tested in this trial

  • standard treatment and routine rehabilitation nursing guidance
  • "Lying-Sitting-Standing" Sequential Baduanjin

Treatment groups

65 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Xiling Qi

Lead sponsor

Second Hospital of Shanxi Medical University

Sponsor institution